Explore the journal
Lutein and zeaxanthin may support selective retinal pathways, but evidence is limited; outcomes depend on dose, formulation, and matching use to trial context.
Read the articleA three-day routine after 50 can still build strength and stamina: two resistance sessions, one brisk movement day, and explicit recovery rules to keep momentum.
Read the articleFasting can improve some markers, but glucose-lowering medicine can alter risk. If you use insulin or SGLT2 drugs, get medical guidance before changing timing.
Read the articleA practical, cautious look at seafood in a longevity diet: what helps, what does not, who should limit intake, and how much uncertainty remains.
Read the articleUncertainty can keep stress on long after a trigger passes; evidence helps separate what works in practice from what remains uncertain for most people.
Read the articleA raised prolactin result is a signal, not a verdict. Repeating the test under stable conditions usually matters more than a single number.
Read the articleA single kidney result can mislead; what matters is how eGFR and urine albumin behave over repeated, clinically grounded measurements, not a one-off snapshot.
Read the articleLate-day caffeine can still reduce sleep quality for many people. Evidence points to staged timing trials, not blanket rules, as the most useful path.
Read the articleGinkgo is widely sold for memory, but evidence is weak or mixed. If using it, check medication interactions first and do not replace clinical care.
Read the articleOver-50 progress comes from consistent strength, balance and recovery. Train steadily, track outcomes, and pause before adding more overload.
Read the articleFind a little clarity
